News

T cells are white blood cells that are important for adaptive immunity. They have unique cell surface receptors that are generated by randomly assorting genes. These receptors allow T cells to ...
March 20, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven ...
Cool Can creator James Vyse left school with no GCSEs and says the reason a self-cooling can has never been made before (despite efforts from the drinks industry) was that previous attempts were far ...
Imagine pressing a button on your favourite drink that immediately cools it and then keeps the liquid frosty. That’s the promise of the new Cool Can by delta H Innovations. The burning question ...
They all failed. But James Vyse a former mixologist turned entrepreneur, cracked the code—not in a corporate lab, but from his bedroom. With no formal engineering background or corporate funding, ...
In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Dyne Therapeutics (DYN – Research Report), with a price target of $66.00. The company’s shares closed ...
Dyne is eyeing an accelerated approval filing for DYNE-251 in early 2026 that would pit the asset against Sarepta’s Exondys 51 in a patient population amenable to exon 51 skipping. Dyne Therapeutics’ ...
Credit: Shutterstock / 24K-Production. Patients with Duchenne muscular dystrophy (DMD) have seen an “unprecedented and sustained” functional improvement in a Phase I/II trial examining Dyne ...
Dyne Therapeutics (DYN) announced new long-term clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 demonstrating unprecedented and sustained functional improvement at the selected ...
But as with all T-shirts — black, white, or otherwise — the Perfect One often proves elusive. And even though the idea of the “perfect” long-sleeved tee is subjective, that didn’t stop ...
The Meta CEO had worn a t-shirt with the phrase ‘Aut Zuck aut nihil’ or ‘Zuck or nothing’, refering to a similar Latin phrase on Roman dictator Julius Caesar. Bluesky CEO Jay Graber poked ...